EV/EBITDA Ratio: 13.79x
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 13.79x is 15% below its 3-year average of 16.25x, near the low end of its 3-year range (11.48x–21.83x).
As of Thursday, June 25, 2026. 0.32% below its 12-month average of 13.83x.
KVUE EV/EBITDA Ratio Chart
KVUE Average EV/EBITDA Ratio Chart
KVUE Current vs Average EV/EBITDA Ratio Chart
KVUE EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
13.79x
EV/EBITDA RATIO AVG TTM
13.83x
EV/EBITDA RATIO AVG 3Y
16.28x
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.32%
CURRENT VS 3Y AVG
-15.28%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
KVUE Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kenvue Inc. (KVUE) | $36.10B | 13.79x | 13.83x | 16.28x | N/A |
| The Kroger Co. (KR)vs › | $36.06B | 10.59x | 10.04x | 8.62x | 8.60x |
| Archer-Daniels-Midland Company (ADM)vs › | $36.19B | 11.90x | 11.57x | 9.08x | 9.65x |
| Kimberly-Clark Corp (KMB)vs › | $35.43B | 13.75x | 12.63x | 14.46x | 15.06x |
| The Hershey Company (HSY)vs › | $37.13B | 19.30x | 19.76x | 17.13x | 18.69x |
| Sysco Corporation (SYY)vs › | $38.54B | 13.27x | 12.64x | 12.33x | 15.17x |
| The Estée Lauder Companies Inc. (EL)vs › | $30.12B | 27.27x | 100.22x | 55.50x | 44.49x |
| Keurig Dr Pepper Inc. (KDP)vs › | $42.72B | 16.71x | 15.66x | 16.12x | 16.87x |
| Kellanova (K)vs › | $29.03B | 15.66x | 16.26x | 16.75x | 14.68x |
| The Kraft Heinz Company (KHC)vs › | $27.20B | N/A | 16.40x | 14.40x | 15.83x |
EV/EBITDA vs. its own history
At 13.8, EV/EBITDA is cheaper than usual, sitting higher than 16% of its 3-year history.
3-year low
11.5
median
15.1
3-year high
21.8
EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Kenvue Inc. (KVUE)?
- The EV/EBITDA ratio for KVUE stock is 13.79x.
- Is Kenvue Inc.'s EV/EBITDA ratio high or low?
- The EV/EBITDA ratio of 13.79x is 15% below its 3-year average of 16.25x, near the low end of its 3-year range (11.48x–21.83x).
- What is the TTM average EV/EBITDA ratio for Kenvue Inc. (KVUE)?
- The TTM average EV/EBITDA ratio for KVUE stock is 13.83x.
- What is the 3Y average EV/EBITDA ratio for Kenvue Inc. (KVUE)?
- The 3Y average EV/EBITDA ratio for KVUE stock is 16.28x.
KVUE EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-24 | 13.79x |
| 2026-06-23 | 13.56x |
| 2026-06-22 | 13.22x |
| 2026-06-18 | 13.38x |
| 2026-06-17 | 13.31x |
| 2026-06-16 | 13.57x |
| 2026-06-15 | 13.46x |
| 2026-06-12 | 13.39x |
| 2026-06-11 | 13.35x |
| 2026-06-10 | 13.34x |
| 2026-06-09 | 13.26x |
| 2026-06-08 | 13.03x |
| 2026-06-05 | 13.13x |
| 2026-06-04 | 12.63x |
| 2026-06-03 | 12.60x |
| 2026-06-02 | 12.89x |
| 2026-06-01 | 12.91x |
| 2026-05-29 | 12.87x |
| 2026-05-28 | 13.09x |
| 2026-05-27 | 13.12x |
| 2026-05-26 | 13.00x |
| 2026-05-22 | 13.02x |
| 2026-05-21 | 12.98x |
| 2026-05-20 | 12.89x |
| 2026-05-19 | 12.79x |
| 2026-05-18 | 12.81x |
| 2026-05-15 | 12.77x |
| 2026-05-14 | 12.82x |
| 2026-05-13 | 12.82x |
| 2026-05-12 | 12.99x |
| 2026-05-11 | 12.80x |
| 2026-05-08 | 13.06x |
| 2026-05-07 | 13.14x |
| 2026-05-06 | 13.98x |
| 2026-05-05 | 13.78x |
| 2026-05-04 | 13.64x |
| 2026-05-01 | 13.82x |
| 2026-04-30 | 13.89x |
| 2026-04-29 | 13.69x |
| 2026-04-28 | 13.89x |
| 2026-04-27 | 13.89x |
| 2026-04-24 | 13.86x |
| 2026-04-23 | 13.86x |
| 2026-04-22 | 13.74x |
| 2026-04-21 | 13.74x |
| 2026-04-20 | 13.92x |
| 2026-04-17 | 13.94x |
| 2026-04-16 | 13.84x |
| 2026-04-15 | 13.74x |
| 2026-04-14 | 13.79x |
| 2026-04-13 | 13.71x |
| 2026-04-10 | 13.77x |
| 2026-04-09 | 13.82x |
| 2026-04-08 | 13.76x |
| 2026-04-07 | 13.37x |
| 2026-04-06 | 13.74x |
| 2026-04-02 | 13.63x |
| 2026-04-01 | 13.79x |
| 2026-03-31 | 13.70x |
| 2026-03-30 | 13.70x |
| 2026-03-27 | 13.88x |
| 2026-03-26 | 13.91x |
| 2026-03-25 | 13.97x |
| 2026-03-24 | 13.90x |
| 2026-03-23 | 13.93x |
| 2026-03-20 | 13.80x |
| 2026-03-19 | 13.82x |
| 2026-03-18 | 13.87x |
| 2026-03-17 | 14.04x |
| 2026-03-16 | 14.00x |
| 2026-03-13 | 13.86x |
| 2026-03-12 | 13.80x |
| 2026-03-11 | 13.96x |
| 2026-03-10 | 14.17x |
| 2026-03-09 | 14.30x |
| 2026-03-06 | 14.44x |
| 2026-03-05 | 14.35x |
| 2026-03-04 | 14.32x |
| 2026-03-03 | 14.29x |
| 2026-03-02 | 14.77x |
| 2026-02-27 | 14.92x |
| 2026-02-26 | 14.84x |
| 2026-02-25 | 14.69x |
| 2026-02-24 | 14.85x |
| 2026-02-23 | 14.81x |
| 2026-02-20 | 14.66x |
| 2026-02-19 | 14.91x |
| 2026-02-18 | 15.05x |
| 2026-02-17 | 14.74x |
| 2026-02-13 | 14.93x |
| 2026-02-12 | 14.83x |
| 2026-02-11 | 14.83x |
| 2026-02-10 | 14.68x |
| 2026-02-09 | 14.59x |
| 2026-02-06 | 14.56x |
| 2026-02-05 | 14.52x |
| 2026-02-04 | 14.48x |
| 2026-02-03 | 14.21x |
| 2026-02-02 | 14.07x |
| 2026-01-30 | 14.08x |
| 2026-01-29 | 13.95x |
| 2026-01-28 | 14.04x |
| 2026-01-27 | 14.15x |
| 2026-01-26 | 14.24x |
| 2026-01-23 | 14.34x |
| 2026-01-22 | 14.31x |
| 2026-01-21 | 14.07x |
| 2026-01-20 | 14.21x |
| 2026-01-16 | 13.95x |
| 2026-01-15 | 13.99x |
| 2026-01-14 | 13.90x |
| 2026-01-13 | 13.83x |
| 2026-01-12 | 13.82x |
| 2026-01-09 | 13.71x |
| 2026-01-08 | 13.81x |
| 2026-01-07 | 13.65x |
| 2026-01-06 | 13.66x |
| 2026-01-05 | 13.70x |
| 2026-01-02 | 14.03x |
| 2025-12-31 | 13.98x |
| 2025-12-30 | 14.04x |
| 2025-12-29 | 13.95x |
| 2025-12-26 | 13.95x |
| 2025-12-24 | 13.96x |
| 2025-12-23 | 13.83x |
| 2025-12-22 | 13.83x |
| 2025-12-19 | 13.83x |
| 2025-12-18 | 13.89x |
| 2025-12-17 | 14.00x |
| 2025-12-16 | 13.98x |
| 2025-12-15 | 13.96x |
| 2025-12-12 | 14.04x |
| 2025-12-11 | 14.03x |
| 2025-12-10 | 14.03x |
| 2025-12-09 | 13.83x |
| 2025-12-08 | 13.66x |
| 2025-12-05 | 13.78x |
| 2025-12-04 | 13.81x |
| 2025-12-03 | 13.80x |
| 2025-12-02 | 13.73x |
| 2025-12-01 | 13.96x |
| 2025-11-28 | 14.05x |
| 2025-11-26 | 13.96x |
| 2025-11-25 | 13.84x |
| 2025-11-24 | 13.66x |
| 2025-11-21 | 13.59x |
| 2025-11-20 | 13.27x |
| 2025-11-19 | 13.21x |
| 2025-11-18 | 13.32x |
| 2025-11-17 | 13.32x |
| 2025-11-14 | 13.60x |
| 2025-11-13 | 13.67x |
| 2025-11-12 | 13.61x |
| 2025-11-11 | 13.64x |
| 2025-11-10 | 13.67x |
| 2025-11-07 | 13.74x |
| 2025-11-06 | 13.47x |
| 2025-11-05 | 13.32x |
| 2025-11-04 | 13.15x |
| 2025-11-03 | 13.26x |
| 2025-10-31 | 11.64x |
| 2025-10-30 | 11.56x |
| 2025-10-29 | 11.61x |
| 2025-10-28 | 11.73x |
| 2025-10-27 | 12.10x |
| 2025-10-24 | 12.04x |
| 2025-10-23 | 12.10x |
| 2025-10-22 | 12.17x |
| 2025-10-21 | 12.00x |
| 2025-10-20 | 12.02x |
| 2025-10-17 | 12.23x |
| 2025-10-16 | 11.48x |
| 2025-10-15 | 12.84x |
| 2025-10-14 | 12.77x |
| 2025-10-13 | 12.82x |
| 2025-10-10 | 13.09x |
| 2025-10-09 | 13.21x |
| 2025-10-08 | 12.73x |
| 2025-10-07 | 12.82x |
| 2025-10-06 | 12.48x |
| 2025-10-03 | 12.56x |
| 2025-10-02 | 12.51x |
| 2025-10-01 | 12.58x |
| 2025-09-30 | 12.82x |
| 2025-09-29 | 12.89x |
| 2025-09-26 | 12.95x |
| 2025-09-25 | 12.79x |
| 2025-09-24 | 13.22x |
| 2025-09-23 | 13.47x |
| 2025-09-22 | 13.29x |
| 2025-09-19 | 14.16x |
| 2025-09-18 | 14.01x |
| 2025-09-17 | 14.16x |
| 2025-09-16 | 14.03x |
| 2025-09-15 | 14.11x |
| 2025-09-12 | 14.58x |
| 2025-09-11 | 14.49x |
| 2025-09-10 | 14.25x |
| 2025-09-09 | 14.50x |
| 2025-09-08 | 14.22x |
| 2025-09-05 | 14.34x |
| 2025-09-04 | 15.56x |
| 2025-09-03 | 15.50x |
| 2025-09-02 | 15.71x |
| 2025-08-29 | 15.67x |
| 2025-08-28 | 15.56x |
| 2025-08-27 | 15.69x |
| 2025-08-26 | 15.72x |
| 2025-08-25 | 15.97x |
| 2025-08-22 | 16.24x |
| 2025-08-21 | 16.13x |
| 2025-08-20 | 16.25x |
| 2025-08-19 | 16.16x |
| 2025-08-18 | 15.91x |
| 2025-08-15 | 15.98x |
| 2025-08-14 | 15.89x |
| 2025-08-13 | 16.30x |
| 2025-08-12 | 16.42x |
| 2025-08-11 | 15.99x |
| 2025-08-08 | 16.07x |
| 2025-08-07 | 16.33x |
| 2025-08-06 | 19.53x |
| 2025-08-05 | 19.69x |
| 2025-08-04 | 20.10x |
| 2025-08-01 | 19.65x |
| 2025-07-31 | 19.53x |
| 2025-07-30 | 19.72x |
| 2025-07-29 | 20.09x |
| 2025-07-28 | 20.24x |
| 2025-07-25 | 20.61x |
| 2025-07-24 | 20.35x |
| 2025-07-23 | 20.38x |
| 2025-07-22 | 20.48x |
| 2025-07-21 | 20.06x |
| 2025-07-18 | 19.96x |
| 2025-07-17 | 19.85x |
| 2025-07-16 | 19.85x |
| 2025-07-15 | 19.50x |
| 2025-07-14 | 19.82x |
| 2025-07-11 | 19.46x |
| 2025-07-10 | 19.13x |
| 2025-07-09 | 19.01x |
| 2025-07-08 | 18.97x |
| 2025-07-07 | 19.12x |
| 2025-07-03 | 19.23x |
| 2025-07-02 | 19.12x |
| 2025-07-01 | 19.17x |
| 2025-06-30 | 19.14x |
| 2025-06-27 | 19.10x |
| 2025-06-26 | 19.28x |
| 2025-06-25 | 19.33x |
| 2025-06-24 | 19.34x |
| 2025-06-23 | 19.48x |
| 2025-06-20 | 19.50x |
| 2025-06-18 | 19.47x |
| 2025-06-17 | 19.53x |
| 2025-06-16 | 19.69x |
| 2025-06-13 | 19.54x |
| 2025-06-12 | 19.99x |
| 2025-06-11 | 19.85x |
Showing the most recent 260 of 787 data points. The chart above shows the full history.
Related Metrics
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry